Isoray to Present at the H.C. Wainwright BioConnect 2021 Conference
Isoray, Inc. (NYSE American: ISR) announced that CEO Lori Woods will present at the H.C. Wainwright BioConnect 2021 Conference, scheduled for January 11-14, 2021. The on-demand presentation will be accessible on the company's Investor Relations webpage starting at 6:00 a.m. EDT on January 11, 2021, and will remain available for 90 days. Isoray is renowned for its innovation in seed brachytherapy, being the exclusive producer of Cesium-131 seeds, enhancing treatment options across various medical fields.
- None.
- None.
RICHLAND, Wash., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator powering expanding treatment options throughout the body, today announced that Chief Executive Officer Lori Woods will present at the H.C. Wainwright BioConnect 2021 Conference. The virtual conference will be held January 11-14, 2021.
The on-demand presentation will be available on Isoray’s Investor Relations section of the Company’s website at https://isoray.com/investors/presentations/ at 6:00 a.m. EDT on Monday, January 11, 2021. It will remain available on the website for 90 days.
About Isoray
Isoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter. Join us on Facebook.
FAQ
When will Isoray's CEO present at the H.C. Wainwright BioConnect 2021 Conference?
Where can I watch Isoray's presentation from the BioConnect Conference?
How long will Isoray's presentation be available to view?
What is the significance of Cesium-131 for Isoray?
What type of company is Isoray?
